NCT01376180View on ClinicalTrials.gov

Drug Use Investigation for LAMICTAL

CompletedOBSERVATIONAL

Enrollment

3,000

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions

Epilepsy

Interventions

DRUG

Lamotrigine

Administered according to the prescribing information in the locally approved label by the authorities

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01376180 - Drug Use Investigation for LAMICTAL | Biotech Hunter | Biotech Hunter